Correlation Between Alterola Biotech and Bionoid Pharma
Can any of the company-specific risk be diversified away by investing in both Alterola Biotech and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alterola Biotech and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alterola Biotech and Bionoid Pharma, you can compare the effects of market volatilities on Alterola Biotech and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alterola Biotech with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alterola Biotech and Bionoid Pharma.
Diversification Opportunities for Alterola Biotech and Bionoid Pharma
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Alterola and Bionoid is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Alterola Biotech and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and Alterola Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alterola Biotech are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of Alterola Biotech i.e., Alterola Biotech and Bionoid Pharma go up and down completely randomly.
Pair Corralation between Alterola Biotech and Bionoid Pharma
Given the investment horizon of 90 days Alterola Biotech is expected to generate 1.5 times less return on investment than Bionoid Pharma. In addition to that, Alterola Biotech is 1.06 times more volatile than Bionoid Pharma. It trades about 0.07 of its total potential returns per unit of risk. Bionoid Pharma is currently generating about 0.11 per unit of volatility. If you would invest 20.00 in Bionoid Pharma on September 14, 2024 and sell it today you would earn a total of 7.00 from holding Bionoid Pharma or generate 35.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 98.44% |
Values | Daily Returns |
Alterola Biotech vs. Bionoid Pharma
Performance |
Timeline |
Alterola Biotech |
Bionoid Pharma |
Alterola Biotech and Bionoid Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alterola Biotech and Bionoid Pharma
The main advantage of trading using opposite Alterola Biotech and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alterola Biotech position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.Alterola Biotech vs. Amexdrug | Alterola Biotech vs. Aion Therapeutic | Alterola Biotech vs. Antisense Therapeutics Limited | Alterola Biotech vs. The BC Bud |
Bionoid Pharma vs. 4Front Ventures Corp | Bionoid Pharma vs. Khiron Life Sciences | Bionoid Pharma vs. BellRock Brands | Bionoid Pharma vs. Elixinol Global |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |